Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.

Gol M., AKAN P., Dogan E., Karas C., Saygili U., Posaci C.

Maturitas, cilt.53, sa.3, ss.252-9, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 53 Sayı: 3
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.maturitas.2005.05.006
  • Dergi Adı: Maturitas
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.252-9
  • Anahtar Kelimeler: conjugated equine estrogen, hormone replacement therapy, raloxifene, nomegestrol acetate, C-reactive protein, homocysteine, HEALTHY POSTMENOPAUSAL WOMEN, CONJUGATED EQUINE ESTROGEN, CORONARY-HEART-DISEASE, CARDIOVASCULAR-DISEASE, PLASMA HOMOCYSTEINE, CONTROLLED-TRIAL, PLUS PROGESTIN, RISK-FACTOR, ATHEROSCLEROSIS, FIBRINOGEN
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objectives: To investigate the effects of conjugated equine estrogen (CEE), CEE plus medroxyprogesterone acetate (MPA), CEE plus Nomegestrol acetate (NA), and raloxifene on serum high sensitivity C-reactive protein (hs-CRP) and homocysteine (Hcy) levels in healthy postmenopausal women.